CHRONIC KIDNEY DISEASE AND HYPERTENSION
Clinical trials for CHRONIC KIDNEY DISEASE AND HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC KIDNEY DISEASE AND HYPERTENSION trials appear
Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASE AND HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to protect failing kidneys
Disease control Recruiting nowThis study is testing if combining two drugs, baxdrostat and dapagliflozin, works better than baxdrostat alone to reduce protein in the urine (a sign of kidney damage) in people with chronic kidney disease and high blood pressure. About 218 adults with these conditions will be ra…
Matched conditions: CHRONIC KIDNEY DISEASE AND HYPERTENSION
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Major trial aims to halt kidney failure and heart deaths
Disease control Recruiting nowThis large, late-stage study is testing whether adding a new drug called baxdrostat to an existing kidney-protective medicine (dapagliflozin) works better than the existing medicine alone. It aims to see if the combination can more effectively slow kidney damage, prevent kidney f…
Matched conditions: CHRONIC KIDNEY DISEASE AND HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC